Longitudinal lung function study in heterozygous PiMZ phenotype subjects

It is a matter of controversy whether subjects who are heterozygous (PiMZ) for alpha 1-antitrypsin deficiency are at risk of developing pulmonary emphysema. To assess the role of MZ phenotype in the development of abnormal lung function the authors performed a 10 year follow-up study of 28 PiMZ subjects, compared to 28 matched-paired normal PiMM subjects. Maximal expiratory flows and mechanical properties of the lungs were studied, in order to determine the changes of the lung function parameters characteristic of pulmonary emphysema. Total lung capacity and residual volume increased, whereas forced expiratory volume in one second, expiratory flows, diffusing capacity of the lungs for carbon monoxide, and static transpulmonary pressures decreased in the PiMZ patients. The majority of the controlled functional parameters were found to deteriorate significantly in PiMZ patients during the 10 year period. Trypsin inhibitory capacity in the PiMZ group (mean +/- SD) was 0.65 +/- 0.17 mg.ml-1 as compared to 1.52 +/- 0.3 mg.ml-1 in the PiMM group. These changes exceeded the values expected as physiological changes due to ageing. The findings in the present longitudinal study--especially the decrease in elasticity, which is the primary pathophysiological damage in alpha 1-antitrypsin deficiency--support the concept that the PiMZ phenotype is a risk factor for the development of pulmonary emphysema at younger age than in those without the deficiency.

This article has been cited by other articles:

				J. B. Wilk, A. Herbert, C. M. Shoemaker, D. J. Gottlieb, and S. Karamohamed Secreted Modular Calcium-binding Protein 2 Haplotypes Are Associated with Pulmonary Function Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 554 - 560. [Abstract] [Full Text] [PDF]

				M. Dahl, C. P. Hersh, N. P. Ly, C. S. Berkey, E. K. Silverman, and B. G. Nordestgaard The protease inhibitor PI*S allele and COPD: a meta-analysis Eur. Respir. J., July 1, 2005; 26(1): 67 - 76. [Abstract] [Full Text] [PDF]

				C P Hersh, M Dahl, N P Ly, C S Berkey, B G Nordestgaard, and E K Silverman Chronic obstructive pulmonary disease in {alpha}1-antitrypsin PI MZ heterozygotes: a meta-analysis Thorax, October 1, 2004; 59(10): 843 - 849. [Abstract] [Full Text] [PDF]

				N. A. Molfino Genetics of COPD Chest, May 1, 2004; 125(5): 1929 - 1940. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]

				G M Corbo, F Forastiere, N Agabiti, V Dell'Orco, R Pistelli, G Massi, C A Perucci, and S Valente Passive smoking and lung function in {alpha}1-antitrypsin heterozygote schoolchildren Thorax, March 1, 2003; 58(3): 237 - 241. [Abstract] [Full Text] [PDF]

				O.S. von Ehrenstein, E. von Mutius, E. Maier, T. Hirsch, D. Carr, W. Schaal, A.A. Roscher, B. Olgemoller, T. Nicolai, and S.K. Weiland Lung function of school children with low levels of {alpha}1-antitrypsin and tobacco smoke exposure Eur. Respir. J., June 1, 2002; 19(6): 1099 - 1106. [Abstract] [Full Text] [PDF]

				M. Dahl, A. Tybjaerg-Hansen, P. Lange, J. Vestbo, and B. G. Nordestgaard Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in {alpha}1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population Ann Intern Med, February 19, 2002; 136(4): 270 - 279. [Abstract] [Full Text] [PDF]

				S. C. McCLOSKEY, B. D. PATEL, S. J. HINCHLIFFE, E. D. REID, N. J. WAREHAM, and D. A. LOMAS Siblings of Patients With Severe Chronic Obstructive Pulmonary Disease Have a Significant Risk of Airflow Obstruction Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1419 - 1424. [Abstract] [Full Text] [PDF]

				J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer Epidemiology of chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2001; 17(5): 982 - 994. [Abstract] [Full Text] [PDF]

				M. Dahl, B. G. Nordestgaard, P. Lange, J. Vestbo, and A. Tybjarg-Hansen Molecular Diagnosis of Intermediate and Severe {{alpha}}1-Antitrypsin Deficiency: MZ Individuals with Chronic Obstructive Pulmonary Disease May Have Lower Lung Function Than MM Individuals Clin. Chem., January 1, 2001; 47(1): 56 - 62. [Abstract] [Full Text] [PDF]

				N. SEERSHOLM, J. T. R. WILCKE, A. KOK-JENSEN, and A. DIRKSEN Risk of Hospital Admission for Obstructive Pulmonary Disease in alpha 1-Antitrypsin Heterozygotes of Phenotype PiMZ Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 81 - 84. [Abstract] [Full Text]

				A. J. Sandford, T. D. Weir, J. J. Spinelli, and P. D. Paré Z and S Mutations of the alpha 1-Antitrypsin Gene and the Risk of Chronic Obstructive Pulmonary Disease Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 287 - 291. [Abstract] [Full Text]